EXPO Strangle Strategy

EXPO (Exponent, Inc.), in the Industrials sector, (Consulting Services industry), listed on NASDAQ.

Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation.

EXPO (Exponent, Inc.) trades in the Industrials sector, specifically Consulting Services, with a market capitalization of approximately $2.95B, a trailing P/E of 27.80, a beta of 0.73 versus the broader market, a 52-week range of 51.91-81.95, average daily share volume of 558K, a public-listing history dating back to 1990, approximately 966 full-time employees. These structural characteristics shape how EXPO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.73 places EXPO roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. EXPO pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on EXPO?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current EXPO snapshot

As of June 30, 2026, spot at $58.43, ATM IV 115.70%, IV rank 21.31%, expected move 33.17%. The strangle on EXPO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this strangle structure on EXPO specifically: EXPO IV at 115.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a EXPO strangle, with a market-implied 1-standard-deviation move of approximately 33.17% (roughly $19.38 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EXPO expiries trade a higher absolute premium for lower per-day decay. Position sizing on EXPO should anchor to the underlying notional of $58.43 per share and to the trader's directional view on EXPO stock.

EXPO strangle setup

The EXPO strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EXPO near $58.43, the first option leg uses a $61.35 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EXPO chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EXPO shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$61.35N/A
Buy 1Put$55.51N/A

EXPO strangle risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

EXPO strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on EXPO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on EXPO

Strangles on EXPO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the EXPO chain.

EXPO thesis for this strangle

The market-implied 1-standard-deviation range for EXPO extends from approximately $39.05 on the downside to $77.81 on the upside. A EXPO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current EXPO IV rank near 21.31% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on EXPO at 115.70%. As a Industrials name, EXPO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EXPO-specific events.

EXPO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EXPO positions also carry Industrials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EXPO alongside the broader basket even when EXPO-specific fundamentals are unchanged. Always rebuild the position from current EXPO chain quotes before placing a trade.

Frequently asked questions

What is a strangle on EXPO?
A strangle on EXPO is the strangle strategy applied to EXPO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With EXPO stock trading near $58.43, the strikes shown on this page are snapped to the nearest listed EXPO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are EXPO strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the EXPO strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 115.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a EXPO strangle?
The breakeven for the EXPO strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current EXPO market-implied 1-standard-deviation expected move is approximately 33.17%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on EXPO?
Strangles on EXPO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the EXPO chain.
How does current EXPO implied volatility affect this strangle?
EXPO ATM IV is at 115.70% with IV rank near 21.31%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related EXPO analysis